A significant increase in ATG9A concentrations was evident in the kidneys of the CIS-treated Gal-3 wild-type mice when compared with Gal-3 wild-type sham control mice, signifying statistical significance (p < 0.001) (Figure 10D). The gene discussed is LGALS3; the disease is in situ carcinoma.